2024
It Takes a Village: An Interdisciplinary Approach to Preparing Internal Medicine Residents to Care for Patients at the Intersection of Women's Health, Gender-Affirming Care, and Health Disparities
Henrich J, Richman I, Rabin T, Gielissen K, Dhond M, Canarie J, Hirschman A, Windham M, Maya S, McNamara C, Pathy S, Bernstein P, Smith R, Vasquez L. It Takes a Village: An Interdisciplinary Approach to Preparing Internal Medicine Residents to Care for Patients at the Intersection of Women's Health, Gender-Affirming Care, and Health Disparities. Journal Of Women's Health 2024, 33: 152-162. PMID: 38190490, DOI: 10.1089/jwh.2023.0217.Peer-Reviewed Original ResearchInternal medicine residentsSelf-reported comfortWomen's healthHealth disparitiesMedicine residentsGender-Affirming CareProportion of residentsCare conditionsHealth equityElectronic surveyMeaningful increaseHealthCareFormative evaluation methodPrevious yearResidentsResident learningHigh levelsPatientsSurgeryGynecologyObstetricsDisparitiesCore team
2022
The role of lung cancer risk and comorbidity in lung cancer screening use
Richman IB, Long JB, Poghosyan H, Sather P, Gross CP. The role of lung cancer risk and comorbidity in lung cancer screening use. Preventive Medicine Reports 2022, 30: 102006. PMID: 36203942, PMCID: PMC9530957, DOI: 10.1016/j.pmedr.2022.102006.Peer-Reviewed Original ResearchLung cancer screeningLung cancer riskDiagnostic chest CTCancer riskLow comorbidityCancer screeningChest CTGreater lung cancer riskHigher lung cancer riskLow-dose computed tomographyCancer screening useLung cancer mortalityDose computed tomographyElectronic health recordsLCS useCohort studyPatient characteristicsEligible adultsCancer mortalityScreening useComorbiditiesComputed tomographyDiagnostic CTDiagnostic imagingPatientsLost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening
Richman IB, Prasad TV, Gross CP. Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening. Preventive Medicine Reports 2022, 29: 101909. PMID: 35911579, PMCID: PMC9326340, DOI: 10.1016/j.pmedr.2022.101909.Peer-Reviewed Original ResearchLung cancer screeningCancer screeningSafety-net primary care practicesPrimary care practicesEligible adultsLung cancerLack of knowledgeHigh riskNational guidelinesPatientsCare practicesScreeningImportant barriersAdultsSmall proportionQualitative studyImportant populationSemi-structured interviewsParticipantsCancerMonthsInsurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis
Richman IB, Long JB, Kyanko KA, Xu X, Gross CP, Busch SH. Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis. JAMA Network Open 2022, 5: e224208. PMID: 35333358, PMCID: PMC8956980, DOI: 10.1001/jamanetworkopen.2022.4208.Peer-Reviewed Original ResearchConceptsCoverage mandateCohort studyBreast cancerPocket paymentsDigital breast tomosynthesisInsurance coveragePoints 2 yearsAffordable Care ActMAIN OUTCOMEScreening mammogramsStudy periodDirect costsBreast tomosynthesisPatient ProtectionCare ActWomenCancerAssociationYearsPrivate insurersPatientsCost sharing
2021
Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years
Richman IB, Long JB, Kunst N, Kyanko K, Xu X, Busch S, Gross CP. Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years. JAMA Internal Medicine 2021, 181: 1665-1668. PMID: 34459853, PMCID: PMC8406208, DOI: 10.1001/jamainternmed.2021.4832.Peer-Reviewed Original Research
2018
Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal.
Wang SY, Dang W, Richman I, Mougalian SS, Evans SB, Gross CP. Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal. Journal Of Clinical Oncology 2018, 36: 1619-1627. PMID: 29659329, PMCID: PMC5978470, DOI: 10.1200/jco.2017.76.5941.Peer-Reviewed Original ResearchConceptsCost-effectiveness analysisChemotherapy useBreast cancerEarly-stage breast cancerStudy designIncremental cost-effectiveness ratioODX recurrence scoreHigh-risk patientsLow-risk patientsRisk of biasCost-effectiveness ratioCost-effectiveness estimatesIndustry fundingDistant recurrenceIndustry-funded studiesClinical characteristicsTumor characteristicsRecurrence scoreChemotherapy decisionsScore groupClinical practiceSystematic reviewODXPatientsCancer
2017
Aspirin for Primary Prevention
Richman IB, Owens DK. Aspirin for Primary Prevention. Medical Clinics Of North America 2017, 101: 713-724. PMID: 28577622, DOI: 10.1016/j.mcna.2017.03.004.BooksMeSH KeywordsAge FactorsAspirinCardiovascular DiseasesColorectal NeoplasmsDiabetes MellitusGastrointestinal HemorrhageHumansHypertensionLipidsMyocardial InfarctionPlatelet Aggregation InhibitorsPractice Guidelines as TopicPrimary PreventionRacial GroupsRisk AssessmentRisk FactorsSex FactorsSmokingStrokeConceptsColorectal cancerPrimary preventionCardiovascular diseaseUS Preventive Services Task ForceNonfatal myocardial infarctionCardiovascular disease riskAdults age 50Intracranial bleedingOlder patientsMyocardial infarctionSelect populationAge 50AspirinAdults 60Disease riskAvailable evidenceRiskCancerDiseasePreventionTask ForceBleedingInfarctionPatientsStroke
2012
European genetic ancestry is associated with a decreased risk of lupus nephritis
Richman IB, Taylor KE, Chung SA, Trupin L, Petri M, Yelin E, Graham RR, Lee A, Behrens TW, Gregersen PK, Seldin MF, Criswell LA. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis & Rheumatism 2012, 64: 3374-3382. PMID: 23023776, PMCID: PMC3865923, DOI: 10.1002/art.34567.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusRenal diseaseLupus nephritisSLE patientsSingle nucleotide polymorphismsSocioeconomic statusEuropean genetic ancestryCross-sectional studyEuropean ancestrySocioeconomic factorsCandidate risk allelesSubset of participantsMeasures of SESDisease durationLupus erythematosusDecreased riskLogistic regressionDiseaseRisk allelesGenetic ancestryNephritisEuropean descentPatientsCandidate genesAfrican Americans